Preclinical evaluation and dosimetry of [64Cu/67Cu]Cu-NGUL for PSMA-targeted prostate cancer theranostics
{{output}}
Background: Prostate-specific membrane antigen (PSMA) is a promising target for imaging and theranostics in prostate cancer (PCa). Current PSMA tracers face limitations due to short half-lives and logistics. We developed a PSMA-t... ...
